| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC2298 |
| Trial ID | NCT04257175 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase2|Phase3 |
| Recruitment status | Recruiting |
| Title | CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression |
| Year | 2020 |
| Country | Israel |
| Company sponsor | Sheba Medical Center |
| Other ID(s) | 6482-19-SMC |
| Cohort 1 | |||||||||||
|
|||||||||||